The increasing phenomenon of consuming 5MeO dimethyltryptamine in Canada presents serious hazards and challenging statutory concerns. Currently, 5meo dimethyltryptamine remains a Class I substance within Canadian CDSA, causing its ownership and distribution unlawful. While vaping delivers the substance quickly, it besides poses additional physical